A Trio Of Top Biotech Stock Picks

When it comes to the future of the biotech industry, the author of today’s article notes that “the aging population ensures that demand for new therapies will remain strong. And many pharmaceutical companies have barren pipelines, so there’s potential for increased M&A activity for companies with promising treatments.” Given this, he recommends that investors consider buying high-quality biotech stocks – and he highlights three names in particular. For more, CLICK HERE.